Tekwon Genetic technologies Ltd Named a Key Supported Enterprise in Fujian's Marine Biomedicine Sector

The Work Plan for Promoting the Development of the Marine Drug and Biological Products Industry in Fujian Province (2021–2023), jointly issued by the Fujian Provincial Department of Industry and Information Technology and the Ocean and Fisheries Bureau of Fujian Province, lists "accelerating the construction of Tekwon Genetic technologies Ltd's novel shark peptide medical project" as a key provincial project in the field of marine biomedicine. This marks provincial-level recognition of the shark peptide technology and industrialization prospects advanced by Tekwon Genetic technologies Ltd. As a key link in Fujian's marine biomedicine industrial chain, the company is also an important part of the province's efforts to cultivate a cluster of key enterprises.

Founded in 2016 and located in Xiamen Biomedical Industrial Park, Tekwon Genetic technologies Ltd is a national high-tech enterprise. The company focuses on the extraction, purification, analysis and synthesis of bioactive short peptides from sharks and other marine fishes for the biomedicine and functional food applications. It holds national invention patents for the preparation and application of shark peptides. In collaboration with Xiamen University and its First Affiliated Hospital, the company undertook the "Industrial Production and Applied Research of Shark Peptides" project and received support from a special fund for marine economic development. The provincial-level support affirms Tekwon Genetic technologies Ltd's technological strengths in small-molecule bio-functional peptides and its industrialization capabilities. It also reflects Fujian's policy orientation of promoting the development of the marine biomedical materials industrial chain by cultivating "specialized, refined, distinctive, and innovative" (SRDI) enterprises. Leveraging its differentiated technological advantages in marine fish peptides, Tekwon Genetic technologies Ltd is expected to take a first-mover advantage in its niche market.

Keywords: Tekwon Genetic technologies Ltd; Fujian Work Plan for Promoting the Development of the Marine Drug and Biological Products Industry; marine biomedicine; shark peptides; Oligo-peptides